Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06777823 · ClinicalTrials.gov registry record · NA
Rejection Sensitivity and Puberty in Mental Health Vulnerability to Social Media Experiences in Early Adolescent Girls
A NA study of Puberty and Psychopathology, sponsored by Washington University School of Medicine.
- Recruiting
- Registry status
- NA
- Development phase
- 250
- Enrollment target
- 1
- Study location
NCT06777823: Recruiting NA study of Puberty and Psychopathology, sponsored by Washington University School of Medicine.
NCT06777823 is a NA study of Puberty and Psychopathology that is actively recruiting participants, run by Washington University School of Medicine. The registered enrollment target is 250 participants, above the 66-participant average among 8 other Puberty trials with a reported enrollment target (279% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06777823, a NA study of Puberty and Psychopathology, is actively recruiting participants, sponsored by Washington University School of Medicine.
- RECRUITING
- Registry status
- NA
- Development phase
- 250 participants
- Enrollment target
- 1
- Study location
Study Summary
This longitudinal study is designed to test bidirectional relationships between preteen girls' mental health and social media experiences. We will explore how pubertal development and experiences of rejection influence these relationships.
Primary Outcome
Measured via the KSADS interview
Conditions Studied
Interventions
- BEHAVIORAL Social Rejection Task
Study Locations (1)
Missouri
- Washington University School of Medicine - St Louis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 250 participants |
| Start Date | 2025-02-05 |
| Est. Completion | 2029-06-30 |
| Phase | NA |
What NCT06777823 shows while recruiting
NCT06777823 is an interventional study that assigns participants to a tested intervention. The registered 250 participants enrollment target is mid-sized for trials with a published cap, above the 66-participant average among 8 other Puberty trials with a reported enrollment target (279% higher).
The record links to 3 conditions, with Puberty appearing as the primary indexed condition, and to 1 intervention - of which Social Rejection Task is the first listed.
NCT06777823 reports a single indexed study location in Missouri.
Frequently Asked Questions
What is clinical trial NCT06777823 about?
NCT06777823 is a clinical study titled "Rejection Sensitivity and Puberty in Mental Health Vulnerability to Social Media Experiences in Early Adolescent Girls". This longitudinal study is designed to test bidirectional relationships between preteen girls' mental health and social media experiences. We will explore how pubertal development and experiences of rejection influence these relationships.
What is the current status of trial NCT06777823?
This trial is currently recruiting. It is a NA study. The enrollment target is 250 participants. The study started on 2025-02-05. Estimated completion is 2029-06-30.
What conditions does trial NCT06777823 study?
This clinical trial studies the following conditions: Puberty, Psychopathology, Rejection Sensitivity.
What interventions are being tested in trial NCT06777823?
The interventions under investigation include: Social Rejection Task (BEHAVIORAL).
Who is sponsoring clinical trial NCT06777823?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06777823 being conducted?
This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Puberty
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06777823's enrollment target sits among peer trials
250 1st of 8 higher than 8 of 8 other Puberty trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Puberty trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
ActiveGirls: Physical Activity, Hormone Health, and Diabetes Risk in Early Adolescence
RECRUITING · NA
-
Skeletal Health and Bone Marrow Composition Among Youth
ACTIVE NOT RECRUITING · NA
-
Investigating the Impact of Obesity on Pubertal Development in Girls
RECRUITING
-
Does Spironolactone Normalize Sleep-wake Luteinizing Hormone Pulse Frequency in Pubertal Girls With Hyperandrogenism?
RECRUITING · Early Phase 1
-
Acute Progesterone Suppression of Wake vs. Sleep Luteinizing Hormone Pulse Frequency in Pubertal Girls With and Without Hyperandrogenism
RECRUITING · Early Phase 1
-
Puberty, Diabetes, and the Kidneys, When Eustress Becomes Distress (PANTHER Study)
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00483249 · 250 participants · NA
Endovascular Exclusion of Thoracoabdominal and/or Paravisceral Abdominal Aortic Aneurysm
- NCT00777712 · 250 participants
Mechanisms Underlying Impaired Diabetic Wound Healing
- NCT01451502 · 250 participants · NA
Infusion of Cell Populations From Unlicensed Umbilical Cord Blood Units
- NCT01771718 · 250 participants
Pilot Study on In-vivo Non-invasive Skin Imaging Using Multiphoton Microscopy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI